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Background: It has been hypothesized that human cytomegalovirus (HCMV) may be associated with breast cancer
progression. However, the role of HCMV infection in breast cancer remains controversial. We aimed to assess
whether HCMV genes (UL122 and UL83) could be detected in breast carcinomas and reinvestigated their possible
association with breast cancer progression. DNA from paraffin-embedded tissues was analyzed by real-time PCR. We
investigated 20 fibroadenomas and 27 primary breast carcinomas (stages II, III, and IV).
Findings: Two carcinomas were positive for HCMV, one was positive for two TaqMan viral detection probes, and
one was positive for a sole TaqMan viral detection probe (UL83), whereas the remainder of the samples was
negative.
Conclusions: Samples studied showed no association between HCMV infection and breast cancer progression.
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The number of new cancer cases and deaths is expected
to increase worldwide. In Mexico, breast cancer has an
incidence of 21.2%, mortality of 13.2%, and 5-year preva-
lence of 30.8% [1]. Cases of breast cancer were recog-
nized from the second decade of life and there was a
peak incidence between 40 and 54 years of age. The ma-
jority of cases were at advanced stages (II, III, and IV).
Metastasis is frequently a final and fatal step in the pro-
gression of solid malignancies. The molecular require-
ments for some of these steps may be specific tissues.
Viruses have been central to modern cancer research
and provide profound insight into both infectious and
non-infectious cancer causes and players in disease pro-
gression. This diverse group of viruses reveals unexpected
connections among innate immunity, immune sensors,
and tumor suppressor signaling that control both viral in-
fection and cancer. Infectious agents can be promoters of
neoplastic transformation. Viruses associated with cancer
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lator, and controversial HMTV/MMTV) have been found
to cause 16.1% of human cancers worldwide [2]. Human
cytomegalovirus (HCMV) is a widespread opportunistic
herpesvirus that causes severe and fatal diseases in im-
munocompromised individuals including those who are
organ transplant recipients, HIV-infected and patients
with cancer. In vitro, HCMV can transform cells and
deregulate other pathways relevant to adenocarcinoma
pathogenesis, especially those affecting the cell cycle,
mutagenesis, apoptosis, and angiogenesis when it has
an oncomodulator role [3]. The purpose of this study
was to determine and investigate a possible association be-
tween progression of breast cancer and HCMV infection
in our tumor collective of advanced breast carcinomas
consisting of 27 primary breast carcinomas and 20 fibro-
adenomas by real-time PCR in order to compare malig-
nant vs. non-malignant tumors.
Materials and methods
Samples of archived paraffin-embedded breast tissue
(years: 2001−2008) were obtained from the Oncology
Hospital of the XXI Century National Medical Center,
Mexican Social Security Institute. The local ethics and
scientific research committees approved the protocol.entral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Table 2 Clinicopathological features of breast cancer
patients included in the study
n = 27 Cases (%)
Histological type
Infiltrating ductal carcinoma 23 (86)
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breast carcinomas (stages II, III, and IV) who had re-
current disease and progression to anthracyclines and
taxanes. All samples had a minimum of 70% cancer
cells. The control group was comprised of 20 samples
of fibroadenomas.
Genomic DNA extraction
To purify DNA from paraffin-embedded tissue, 10-μm-
thick slices of carcinomas and fibroadenomas were subse-
quently treated with 900 μL of xylene to remove residual
xylene. The tissue was washed twice with 1000 μL of
100% ethanol and was finally resuspended in 540 μL of
RLT buffer (Qiagen). Dewaxed tissues were incubated
three times with 60 μL of proteinase K at 56°C/24 h. DNA
was extracted with AllPrep DNA/RNA/Protein Mini Kit
(Qiagen) according to the manufacturer’s instructions.
Briefly, lysated tissues were placed in a column and spun
for 1 min/10000 rpm; later, the column was washed twice
with AW1 and AW2 buffers. Finally, the DNA was eluted
with 25 μL of EB buffer preheated to 70°C. DNA quantifi-
cation was performed at 260 nm in Nanodrop (Thermo
Scientific).
Multiplex PCR for glyceraldehyde-3-phosphate-
dehydrogenase
DNA integrity was established by the Multiplex PCR kit
(Qiagen) for glyceraldehyde-3-phosphate-dehydrogenase
(GADPH) amplification with increase of 100 bp (range:
100–700 bp) [4]. PCR was performed with 5 ng genomic
DNA in a 12.5 μL volume containing 1X Master Mix
and 0.2 μM of each primer (Table 1). Amplification was
performed in a Biometra Thermocycler (T Professional)
as follows: 95°C/15 min for 40 cycles at 94°C/30 sec; at
57°C/90 sec; at 72°C/90 sec and, finally, at 72°C/10 min.
PCR products were separated by electrophoresis on
agarose gel 2.0%, stained with 1X Gel network (Biotium)
and visualized under an ultraviolet light transilluminator
and photodocumenter system (Syngene).Table 1 Sequence primers (multiplex PCR for
glyceraldehyde-3-phosphate-dehydrogenase
amplification)
Forward primers Reverse primers Base
pairs
GTT CCA ATA TGA TTC CAC CC CTC CTG GAA GAT GGT GAT GG 100
AGG TGG AGC GAG GCT AGC TTT TGC GGT GGA AAT GTC CT 200
AGG TGA GAC ATT CTT GCT GG TCC ACT AAC CAG TCA GCG TC 300
ACA GTC CAT GCC ATC ACT GC GCT TGA CAA AGT GGT CGT TG 400
AGC CCC TAA GGT CTT CAA GC CAT GCC TGT AGC TGG GAC TA 500
GGC TCC CTT GGG TAT ATG GT GGA GCC AGT CTT GGA TGA 600
CCC CAC ACA CAT GCA CTT AC AAT GAA GGG GTC ATT GAT GG 700Detection of HCMV by real-time PCR
HCMV detection was performed by real-time PCR
(qPCR), amplifying a 96-bp fragment, immediate early
gene expression, Ie2 (UL122, forward primer: GGCTC
ACCTCGTCAATCTTGA; reverse primer: AGAAGGT
GCGCAATATCATGAAAGA; TaqMan probe: FAM-
CCCCCTTCTGCACACCC) and 84 bp, late gene ex-
pression, pp65 (UL83, forward primer: GGGACACAA
CACCGTAAAGC; reverse primer: GTGGAAGAGGA
CCTAACGATGAC; TaqMan probe: FAM-CCGCAAC
CCTTCATGC). qPCR was performed with 100 ng of
genomic DNA at a final volume of 8 μL: 1X TaqMan Uni-
versal PCR Master Mix (Applied Biosystems), 0.54 μL
UL122- or 0.54 μL UL83- TaqMan probe. Amplification
was performed in an ABI 7500 thermal cycler as follows:
60°C/2 min and 95°C/10 min, and 40 cycles: 95°C/15 sec
and 60°C/1 min, and 60°C/30 sec. Positive control was
done with HCMV strain AD-169 (ATCC VR-583). Nega-











T0-T2 tumor size <5 cm of diameter; T3 tumor size >5 cm of diameter; T4
tumor any size with extension to skin or chest.
ER, estrogen receptor; PR, progesterone receptor; NA, data not available.
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DNA. All qPCR reactions were carried out in duplicate.
Statistical analysis
We used Fisher’s exact test to compare the number
cytomegalovirus-positive samples between fibroadenomas
and breast carcinomas.
Results
The study group included subjects with a mean age of
53.26 ± 11.99 years (range: 27−76 years). Mean overall
survival was 44 months (range: 12−84 months). All had
progression with active tumor sites affecting bone, softFigure 1 Quality control for breast carcinomas and fibroadenomas. M
10−18 fibroadenomas. (B) Lines 27, 37−45 breast carcinomas; 19−30, 46 an
AD-169 (ATCCW VR-583); control negative (−), DNA white blood cells fromtissue, liver, lung, and central nervous system. The control
group had a mean age of 45 ± 9.27 years (range: 27−67
years). Females with fibroadenoma were younger than fe-
males with carcinoma.
Sample 19 was HCMV-positive with both TaqMan
probes: one detected an immediate early gene (synonym
of viral replication) and the other detected a late gene
(presence of virus). The sample ´eight´ only tested posi-
tive for a late gene. The remaining samples were HCMV-
negative.
Patients positive for HCMV were detected in undiffe-
rentiated infiltrating ductal carcinomas and Luminal A
molecular subtype. A 54-year-old patient had 49 monthsultiplex PCR for GADPH. (A) Lines 1−9 and 19−26 breast carcinomas;
d 47 fibroadenomas. Base pairs (bp); control positive (+), HCMV strain
healthy individual (blood donor) and reaction mix without DNA.
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and undetermined p53, whereas another patient aged 68
years had 54 months of surveillance: T4, IIB, ER+, PR+,
Her2/Neu-negative, p53-positive. Patient data are shown
in Table 2. There was no association (p = 0.50) between
the presence of HCMV and the clinicopathological pa-
rameters (survival, progression, tumoral activity sites,
alive without disease, alive with stable disease, alive with-
out disease progression, died of disease) analyzed. Mo-
lecular detection was qualitative and HCMV-positive
samples had a high number (>35) of threshold of detec-
tion (Ct) cycles.
Discussion
This study analyzed breast carcinoma ‘progression’ ac-
cording to HCMV infection. By investigating progression
of breast carcinoma resection specimens, we were able
to study 27 primary tumors (stages II, III, and IV) and
20 fibroadenomas by qPCR. Several studies have been
linked to HCMV infections with malignant phenotype,
particularly with glioblastoma [5]. We are unable to sup-
port these latter findings with our collective tumors.
Only two primary tumors (7.4%) from all 27 specimens
(100%) were HCMV-positive qualitatively, with the re-
mainder being negative. These results were coincident
with colon cancer [6] but not coincident with other re-
ports of breast cancer [7] where the target viral genes,
molecular techniques and inclusion criteria of samples
were different. The fact that we examined quality DNA
from tumor specimens of breast carcinoma by Multiplex
PCR for GAPDH [4] in all samples amplified a set of
different-sized targets (Figure 1). PCR is able to detect
acute as well as latent infections. PCR positivity in the
two primary carcinomas of our tumor collective is due
to replication and viral latency and the other to only
a latent virus. Positivity was observed in the primary
tumor. There was no positivity in the fibroadenomas.
We were unable to support the finding that HCMV in-
fection may be correlated with tumor progression. The
only mechanism compatible with the observations re-
ported is the “hit-and-run” hypothesis, which claims that
a virus can mediate cellular transformation through an
initial “hit”, whereas maintenance of the transformed state
is compatible with viral molecule (“run”) loss. Although
the concept of hit-and-run transformation has been con-
troversial for many years, it remains the only plausible
explanation for the observations of neoplastic transform-
ation following in vitro transfection of herpesvirus and
cytomegalovirus DNA, which have been presented by
multiple laboratories for more than two decades [8].
Conclusions
In the samples analyzed, there was no statistically signi-
ficant association between malignant vs. non-malignanttumors (p = 0.50) and breast cancer progression vs.
HCMV infection (p = 0.50), but we detected HCMV
in two malignant tumors samples: one of which was posi-
tive for two detection probes, whereas the other sample
was positive for one.Competing interests
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